Clinical Trial Update: Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase Ib trial update evaluating gemcitabine plus cisplatin or carboplatin with dovitinib in patients with advanced solid tumors, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Dovitinib (dovitinib)
• Gemzar (gemcitabine)
• Paraplatin (Carboplatin)
• Platinol (cisplatin)

Snippet

Sponsor: Matthew Galsky | Conditions: Solid Tumors, Bladder Cancer | Phase 1 | Status: TERMINATED